Importantly, individual disruption of the RING or BRCT recruitment pathways were insufficient to entirely abolish BRCA1 foci, shedding light on how BRCA1 mutant cancers utilize hypomorphic proteins, which often lack these domains, to contribute to residual HR activity and PARPi resistance20,29,38–40. Here, BRCA1 is linked to cancer.